267 related articles for article (PubMed ID: 24714603)
1. Recurrence of hepatitis C after liver transplantation.
Vinaixa C; Rubín A; Aguilera V; Berenguer M
Ann Gastroenterol; 2013; 26(4):304-313. PubMed ID: 24714603
[TBL] [Abstract][Full Text] [Related]
2. To transplant or not to transplant recurrent hepatitis C and liver failure.
Forman LM
Clin Liver Dis; 2003 Aug; 7(3):615-29. PubMed ID: 14509530
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of recurrent hepatitis C infection after liver transplantation].
Filipec Kanizaj T; Colić Cvrlje V; Mrzljak A; Ostojić R
Acta Med Croatica; 2009 Dec; 63(5):451-7. PubMed ID: 20198907
[TBL] [Abstract][Full Text] [Related]
4. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation and hepatitis C.
Rubín A; Aguilera V; Berenguer M
Clin Res Hepatol Gastroenterol; 2011 Dec; 35(12):805-12. PubMed ID: 21963086
[TBL] [Abstract][Full Text] [Related]
6. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
[TBL] [Abstract][Full Text] [Related]
7. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
Duarte-Rojo A; Veldt BJ; Goldstein DD; Tillman HL; Watt KD; Heimbach JK; McHutchison JG; Poterucha JJ; Vargas-Vorackova F; Charlton MR
Transplantation; 2012 Jul; 94(2):197-203. PubMed ID: 22766768
[TBL] [Abstract][Full Text] [Related]
8. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of recurrent HCV infection after liver transplantation].
Kanizaj TF; Colić-Cvrlje V; Mrzljak A; Ostojić R
Acta Med Croatica; 2013 Oct; 67(4):373-81. PubMed ID: 24984339
[TBL] [Abstract][Full Text] [Related]
10. Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Antonini TM; Furlan V; Teicher E; Haim-Boukobza S; Sebagh M; Coilly A; Bonhomme-Faivre L; Roque-Afonso AM; Vittecoq D; Samuel D; Taburet AM; Duclos-Vallée JC
AIDS; 2015 Jan; 29(1):53-8. PubMed ID: 25387314
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of viral hepatitis in solid organ transplantation].
Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
[TBL] [Abstract][Full Text] [Related]
12. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus and liver transplantation.
Ahmed A; Keeffe EB
Clin Liver Dis; 2001 Nov; 5(4):1073-90. PubMed ID: 11685796
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
17. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
18. The natural history of recurrent hepatitis C and what influences this.
Gane EJ
Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
[TBL] [Abstract][Full Text] [Related]
19. Natural history of hepatitis C and outcomes following liver transplantation.
Charlton M
Clin Liver Dis; 2003 Aug; 7(3):585-602. PubMed ID: 14509528
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]